Search

Author/Creator Chan, Milagros

1. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial. Issue 3 (March 2022)

Authors:
Kremsner, Peter G; Ahuad Guerrero, Rodolfo Andrés; Arana-Arri, Eunate; Aroca Martinez, Gustavo Jose; Bonten, Marc; Chandler, Reynaldo; Corral, Gonzalo; De Block, Eddie Jan Louis; Ecker, Lucie; Gabor, Julian Justin; Garcia Lopez, Carlos Alberto; Gonzales, Lucy; Granados González, María Angélica; G...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 3(2022)
Page Start:
329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Persistence of protective anti-poliovirus antibody levels in 4-year-old children previously primed with Picovax®, a trivalent, aluminium-adjuvanted reduced dose inactivated polio vaccine. Issue 40 (22nd September 2022)

Authors:
Sáez-Llorens, Xavier; Chan, Milagros; DeAntonio, Rodrigo; Petersen, Torben; Olesen, Charlotte; Jensen, Jens Søndergaard; Sørensen, Charlotte; Ekstrand, Lena Messerschmidt; Czort, Michaela Katrine; Kristensen, Hans-Henrik; Thulstrup, Niels; Christoffersen, Dorte Birk
Journal:
Vaccine
Issue:
Volume 40:Issue 40(2022)
Page Start:
5835
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search